1. Home
  2. GGAL vs RGEN Comparison

GGAL vs RGEN Comparison

Compare GGAL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Financiero Galicia S.A.

GGAL

Grupo Financiero Galicia S.A.

HOLD

Current Price

$44.97

Market Cap

6.8B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$172.94

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGAL
RGEN
Founded
1905
1981
Country
Argentina
United States
Employees
N/A
N/A
Industry
Commercial Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.6B
IPO Year
2001
1995

Fundamental Metrics

Financial Performance
Metric
GGAL
RGEN
Price
$44.97
$172.94
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$69.00
$167.67
AVG Volume (30 Days)
894.1K
976.8K
Earning Date
03-07-2023
05-05-2026
Dividend Yield
3.70%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.24
Revenue
N/A
$141,236,000.00
Revenue This Year
$62.29
$14.30
Revenue Next Year
$22.88
$14.52
P/E Ratio
$13.36
$708.42
Revenue Growth
N/A
35.10
52 Week Low
$25.89
$100.99
52 Week High
$62.11
$188.73

Technical Indicators

Market Signals
Indicator
GGAL
RGEN
Relative Strength Index (RSI) 49.49 56.11
Support Level $44.86 $156.65
Resistance Level $45.07 $173.10
Average True Range (ATR) 1.77 7.17
MACD 0.40 -1.35
Stochastic Oscillator 94.58 34.67

Price Performance

Historical Comparison
GGAL
RGEN

About GGAL Grupo Financiero Galicia S.A.

Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. The company generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: